Hype over GLP-1s may be creating false hopes for people with diabetes
The majority of people with diabetes are now aware of GLP-1s, a class of medication indicated for blood sugar control that often produces notable weight loss as part of the process. More than half (57%) have discussed these medications with their doctor, and of that group, 71% have been prescribed or recommended a prescription.
79% have inquired about GLP-1s to help them manage their diabetes
53% are also interested in the weight loss possibilities
43% believe GLP-1s can assist with cardiovascular health risks
While the drugs have been shown to both improve glycemic and metabolic health as well as produce benefits of weight loss, they should be used in conjunction with lifestyle and long-term support to maximize and sustain results. However, a majority of respondents (57%) view these weight loss medications as the only thing they need to achieve their health goals. Respondents identifying as male (63%), those living in urban areas (67%), and those on commercial insurance (63%) were among the most likely to believe this statement. Those beliefs can be problematic for people living with diabetes, especially since multiple studies 3 have indicated that users can regain an average of two-thirds of the weight lost after discontinuing the medication and may also see their cardiovascular health markers revert back to their original state.
“GLP-1 drugs hold great potential to help tackle the obesity and diabetes epidemics plaguing Americans, and it’s critical that the healthcare ecosystem ensures access to these medications for those who need them most. However, they’re not a silver bullet. “To make the most of the benefits, we need to ensure they are fully integrated into holistic, personalized efforts to improve self- management and lifestyle decisions that can lead to sustainable weight loss and improved cardiovascular and metabolic health.” Dr. Angela Fitch Founder and Chief Medical Officer of knownwell, a weight-inclusive healthcare company that offers holistic, evidence-based care and a member of CCS’ Scientific Advisory Council
© 2024 CCS Medical
4
Made with FlippingBook interactive PDF creator